Hunan Mingrui Pharmaceutical

Hunan Mingrui Pharmaceutical is a specialized pharmaceutical company based in Changsha, China, focusing on the research, development, and manufacturing of high-end generic and innovative drugs. The company primarily targets respiratory diseases, endocrine disorders, and cardiovascular conditions, with a particular expertise in complex inhaled drug delivery systems such as dry powder inhalers and nebulized solutions. Established in 2013, Hunan Mingrui operates advanced manufacturing facilities that comply with GMP standards to support its portfolio of treatments for asthma and COPD. The firm integrates R&D with commercial production to provide cost-effective therapeutic options for chronic disease management. Their strategy centers on overcoming technical barriers in the formulation of respiratory medicines to compete in both domestic and international markets.